Nature Communications (Nov 2017)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

  • Daiyin Tian,
  • Michael B. Battles,
  • Syed M. Moin,
  • Man Chen,
  • Kayvon Modjarrad,
  • Azad Kumar,
  • Masaru Kanekiyo,
  • Kevin W. Graepel,
  • Noor M. Taher,
  • Anne L. Hotard,
  • Martin L. Moore,
  • Min Zhao,
  • Zi-Zheng Zheng,
  • Ning-Shao Xia,
  • Jason S. McLellan,
  • Barney S. Graham

DOI
https://doi.org/10.1038/s41467-017-01858-w
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 7

Abstract

Read online

Monoclonal antibodies to prevent respiratory syncytial virus (RSV) disease are under development, but the molecular requirements for cross-subtype neutralization are unclear. Here, the authors show that residue 201 in RSV fusion protein determines subtype specific neutralization for the clinically-relevant monoclonal antibody, 5C4.